Close

Leerink Partners Cuts Price Target on Conmed (CNMD) to $43; Reiterates Market Perform

Go back to Leerink Partners Cuts Price Target on Conmed (CNMD) to $43; Reiterates Market Perform

Conmed (CNMD) Tops Q3 EPS by 1c

October 27, 2016 5:19 PM EDT

Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.41, $0.01 better than the analyst estimate of $0.40. Revenue for the quarter came in at $184.8 million versus the consensus estimate of $180.13 million.

Conmed reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Conmed (CNMD) click here.

... More

Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report

October 26, 2016 2:46 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 259kContinuing Claims - no Street consensusDurable Orders - Street sees 0.3%Durable Orders: ex. Transportation - Street sees 0.3%

Earnings:

Acorda Therapeutics (Nasdaq: ACOR) - no Street consensus
Aetna (NYSE: AET) - consensus EPS $2.03
Agenus (Nasdaq: AGEN) - consensus loss $0.29
Air Products (NYSE:... More